Therapeutic delivery to the peritoneal lymphatics: Current understanding, potential treatment benefits and future prospects
- 1 August 2019
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 567, 118456
Abstract
No abstract availableKeywords
Funding Information
- Health Research Council of New Zealand
This publication has 102 references indexed in Scilit:
- Lymphatic vasculature mediates macrophage reverse cholesterol transport in miceJournal of Clinical Investigation, 2013
- Effective Delivery of PEGylated siRNA-Containing Lipoplexes to Extraperitoneal Tumours following Intraperitoneal AdministrationJournal of Drug Delivery, 2011
- Angptl4 Protects against Severe Proinflammatory Effects of Saturated Fat by Inhibiting Fatty Acid Uptake into Mesenteric Lymph Node MacrophagesCell Metabolism, 2010
- Adaptive immunity and adipose tissue biologyTrends in Immunology, 2010
- Drug Delivery Systems for Intraperitoneal TherapyPharmaceutical Research, 2010
- Effects of Carrier on Disposition and Antitumor Activity of Intraperitoneal PaclitaxelPharmaceutical Research, 2007
- Lymphatic Drainage of the Peritoneal Space: A Pattern Dependent on Bowel LymphaticsAnnals of Surgical Oncology, 2006
- Regulation of B1 cell migration by signals through Toll-like receptorsJournal of Experimental Medicine, 2006
- Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesotheliomaJournal of Cancer Research and Clinical Oncology, 1992
- The passage of particulate matter from the peritoneal cavity into the lymph vessels of the diaphragmThe Anatomical Record, 1948